Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Burkard

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The British Journal of Psychiatry. Supplement|October 1, 1989
Pre-clinical pharmacology of moclobemide. A review of published studiesW P Burkard, M Da Prada, H H Keller, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Some basic aspects of reversible inhibitors of monoamine oxidase-AM Da Prada, R Kettler, W P Burkard, et al.
Journal of Neural Transmission. Supplementum|January 1, 1989
Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitorsM Da Prada, R Kettler, H H Keller, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brainH H Keller, W P Burkard, L Pieri, et al.
Archiv Der Pharmazie|January 1, 1990
An opioid agonist with preference for kappa-opioid receptors: (-)-N-cyclopropylmethylmorphinan-6-oneH Schmidhammer, E Trenker, W P Burkard, et al.
Neurochemistry International|March 1, 1992
New insight into structural and stereochemical requirements for selective, high affinity ligands at the dopamine D2 receptorR Imhof, T Godel, W P Burkard, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type AM Da Prada, R Kettler, H H Keller, et al.
Arzneimittel-Forschung|August 1, 1989
In vitro pharmacological properties of a series of isoprenaline derivativesR Eigenmann, W P Burkard, M Holck, et al.
Pharmacopsychiatry|November 1, 1988
Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptorJ R Martin, L Pieri, E P Bonetti, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
Some neuropharmacological effects of Ro 11-2465--a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HTM Da Prada, H H Keller, W P Burkard, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The British Journal of Psychiatry. Supplement|October 1, 1989
Pre-clinical pharmacology of moclobemide. A review of published studiesW P Burkard, M Da Prada, H H Keller, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Some basic aspects of reversible inhibitors of monoamine oxidase-AM Da Prada, R Kettler, W P Burkard, et al.
Journal of Neural Transmission. Supplementum|January 1, 1989
Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitorsM Da Prada, R Kettler, H H Keller, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brainH H Keller, W P Burkard, L Pieri, et al.
Archiv Der Pharmazie|January 1, 1990
An opioid agonist with preference for kappa-opioid receptors: (-)-N-cyclopropylmethylmorphinan-6-oneH Schmidhammer, E Trenker, W P Burkard, et al.
Neurochemistry International|March 1, 1992
New insight into structural and stereochemical requirements for selective, high affinity ligands at the dopamine D2 receptorR Imhof, T Godel, W P Burkard, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type AM Da Prada, R Kettler, H H Keller, et al.
Arzneimittel-Forschung|August 1, 1989
In vitro pharmacological properties of a series of isoprenaline derivativesR Eigenmann, W P Burkard, M Holck, et al.
Pharmacopsychiatry|November 1, 1988
Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptorJ R Martin, L Pieri, E P Bonetti, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
Some neuropharmacological effects of Ro 11-2465--a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HTM Da Prada, H H Keller, W P Burkard, et al.
Pageof 4